Predicted coronary risk for adults with coronary heart disease and low HDL-C: an analysis from the US National Health and Nutrition Examination Survey

References

• Centers for Disease Control and Prevention (CDC). Heart disease facts and statistics. 2008. Available from http://www.cdc. gov/heartdisease/facts.htm[Last accessed 9 Jul 2008]1Centers for Disease Control and Prevention (CDC). Heart disease facts and statistics. 2008. Available from http://www.cdc. gov/heartdisease/facts.htm[Last accessed 9 Jul 2008]
   Google Scholar
• World Health Organization. The atlas of heart disease and stroke. 2008. Available from http://www.who.int/cardiovascular_ diseases/resources/atlas/en/[Last accessed 9 Jul 2008]2World Health Organization. The atlas of heart disease and stroke. 2008. Available from http://www.who.int/cardiovascular_ diseases/resources/atlas/en/[Last accessed 9 Jul 2008]
   Google Scholar
• American Heart Association and American Stroke Association. Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25–1463American Heart Association and American Stroke Association. Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25–146
   PubMed Web of Science ®Google Scholar
• Liu JL, Maniadakis N, Gray A. et al. The economic burden of coronary heart disease in the UK. Heart 2002;88:597–6034Liu JL, Maniadakis N, Gray A. et al. The economic burden of coronary heart disease in the UK. Heart 2002;88:597–603
   PubMed Web of Science ®Google Scholar
• Curb JD, Abbott RD, Rodriguez BL. et al. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res 2004;45:948–535Curb JD, Abbott RD, Rodriguez BL. et al. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res 2004;45:948–53
   PubMed Web of Science ®Google Scholar
• Sharrett AR, Ballantyne CM, Coady SA. et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001;104:1108–136Sharrett AR, Ballantyne CM, Coady SA. et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001;104:1108–13
   PubMed Web of Science ®Google Scholar
• Gordon DJ, Probstfield JL, Garrison RJ. et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8–157Gordon DJ, Probstfield JL, Garrison RJ. et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8–15
   PubMed Web of Science ®Google Scholar
• Turner RC, Millns H, Neil HA. et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) [comment]. BMJ 1998;316:823–88Turner RC, Millns H, Neil HA. et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) [comment]. BMJ 1998;316:823–8
   PubMed Web of Science ®Google Scholar
• Barter P, Gotto AM, Phil D. et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007;357:1301–109Barter P, Gotto AM, Phil D. et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007;357:1301–10
   PubMed Web of Science ®Google Scholar
• Rubins HB, Robins SJ, Collins D. et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341:410–810Rubins HB, Robins SJ, Collins D. et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341:410–8
   PubMed Web of Science ®Google Scholar
• D’Agostino RB, Russell MW. et al. Primary and subsequent coronary risk appraisal: new results from The Framingham Study. Am Heart J 2000;139:272–8111D’Agostino RB, Russell MW. et al. Primary and subsequent coronary risk appraisal: new results from The Framingham Study. Am Heart J 2000;139:272–81
   PubMed Web of Science ®Google Scholar
• National Center for Health Statistics. National health and nutrition examination survey. 2008. Available from http://www.cdc. gov/nchs/nhanes.htm[Last accessed 9 Jul 2008]12National Center for Health Statistics. National health and nutrition examination survey. 2008. Available from http://www.cdc. gov/nchs/nhanes.htm[Last accessed 9 Jul 2008]
   Google Scholar
• National Center for Health Statistics and Centers for Disease Control and Prevention (CDC). The National Health and Nutrition Examination Survey (NHANES) Analytic and reporting guidelines. 2005. Available from http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/nhanes_analytic_guidelines_dec_ 2005.pdf[Last accessed 15 April 2008]13National Center for Health Statistics and Centers for Disease Control and Prevention (CDC). The National Health and Nutrition Examination Survey (NHANES) Analytic and reporting guidelines. 2005. Available from http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/nhanes_analytic_guidelines_dec_ 2005.pdf[Last accessed 15 April 2008]
   Google Scholar
• Assmann G, Schulte H, von Eckardstein A, et al. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996; 124:11–2014Assmann G, Schulte H, von Eckardstein A, et al. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996; 124:11–20
   Google Scholar
• Strandberg TE, Pitkala KH, Berglind S. et al. Multifactorial intervention to prevent recurrent cardiovascular events in patients 75 years or older: the Drugs and Evidence-Based Medicine in the Elderly (DEBATE) study: a randomized, controlled trial. Am Heart J 2006;152:585–9215Strandberg TE, Pitkala KH, Berglind S. et al. Multifactorial intervention to prevent recurrent cardiovascular events in patients 75 years or older: the Drugs and Evidence-Based Medicine in the Elderly (DEBATE) study: a randomized, controlled trial. Am Heart J 2006;152:585–92
   PubMed Web of Science ®Google Scholar
• Munoz MA, Vila J, Cabanero M. et al. Efficacy of an intensive prevention program in coronary patients in primary care, a randomised clinical trial. Int J Cardiol 2007;118:312–2016Munoz MA, Vila J, Cabanero M. et al. Efficacy of an intensive prevention program in coronary patients in primary care, a randomised clinical trial. Int J Cardiol 2007;118:312–20
   PubMed Web of Science ®Google Scholar
• Robinson JG, Maheshwari N. A ‘poly-portfolio’ for secondary prevention: a strategy to reduce subsequent events by up to 97% over five years. Am J Cardiol 2005;95:373–817Robinson JG, Maheshwari N. A ‘poly-portfolio’ for secondary prevention: a strategy to reduce subsequent events by up to 97% over five years. Am J Cardiol 2005;95:373–8
   PubMed Web of Science ®Google Scholar
• Hyre AD, Muntner P, Menke A. et al. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Am J Epidemiol 2007;17:548–5518Hyre AD, Muntner P, Menke A. et al. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Am J Epidemiol 2007;17:548–55
   PubMed Web of Science ®Google Scholar
• D’Agostino RB, Sr, Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286:180–719D’Agostino RB, Sr, Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286:180–7
   PubMed Web of Science ®Google Scholar